Low-dose Lymphocyte Immunotherapy Rebalances the Peripheral Blood Th1/Th2/Treg Paradigm in Patients with Unexplained Recurrent Miscarriage

The published results regarding lymphocytes immunotherapy for unexplained recurrent miscarriage (uRM) patients are conflicting due to different screening criteria and therapeutic protocols. The objective of the present study is to evaluate the effectiveness of immunotherapy using low-dose lymphocytes in patients with uRM and Th1/Th2/Treg paradigm disorders.